{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T14:57:16Z","timestamp":1772117836590,"version":"3.50.1"},"publisher-location":"Chichester, UK","reference-count":78,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd001769.pub2","type":"reference-entry","created":{"date-parts":[[2013,8,23]],"date-time":"2013-08-23T07:14:43Z","timestamp":1377242083000},"source":"Crossref","is-referenced-by-count":17,"title":["Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures"],"prefix":"10.1002","author":[{"given":"Sarah J","family":"Nolan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony G","family":"Marson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Pulman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catrin","family":"Tudur Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,8,23]]},"reference":[{"key":"10.1002\/14651858.CD001769.pub2-BIB1|cit1","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1136\/jnnp.48.7.639","article-title":"A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy","volume":"48","author":"Callaghan","year":"1985","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD001769.pub2-BIB2|cit2","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1528-1157.1994.tb02448.x","article-title":"Impact of valproate and phenytoin on cognitive function in elderly patients: results of a single-blind randomized comparative study","volume":"35","author":"Craig","year":"1994","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001769.pub2-BIB3|cit3","first-page":"42","article-title":"Randomised 36-month comparative study of valproic acid, phenytoin, phenobarbital and carbamazepine efficacy in patients with newly diagnosed epilepsy with partial complex seizures","volume":"38 (Suppl 3)","author":"Czapinski","year":"1997","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001769.pub2-BIB4|cit4","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(96)90074-4","article-title":"Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy","volume":"347","author":"Silva","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001769.pub2-BIB5|cit5","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/j.1469-8749.1991.tb14917.x","article-title":"Cognitive impairment in new cases of epilepsy randomly assigned to carbamazepine, phenytoin and sodium valproate","volume":"33","author":"Forsythe","year":"1991","journal-title":"Developmental Medicine and Child Neurology"},{"key":"10.1002\/14651858.CD001769.pub2-BIB6|cit6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1136\/jnnp.58.1.44","article-title":"Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial","volume":"58","author":"Heller","year":"1995","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD001769.pub2-BIB7|cit7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0896-6974(05)80021-0","article-title":"Efficacy and safety of valproic acid versus phenytoin as sole therapy for newly diagnosed primary generalized tonic-clonic seizures","volume":"5","author":"Ramsay","year":"1992","journal-title":"Journal of Epilepsy"},{"issue":"8","key":"10.1002\/14651858.CD001769.pub2-BIB8|cit8","first-page":"606","article-title":"Comparison of sodium valproate and phenytoin as single drug treatment in generalised and partial epilepsy","volume":"39","author":"Rastogi","year":"1991","journal-title":"Journal of the Association of Physicians of India"},{"key":"10.1002\/14651858.CD001769.pub2-BIB9|cit9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1528-1157.1981.tb04330.x","article-title":"Comparison of sodium valproate and phenytoin as single drug treatment in epilepsy","volume":"22","author":"Shakir","year":"1981","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001769.pub2-BIB10|cit10","first-page":"549","article-title":"Comparison of phenobarbitone, phenytoin with sodium valproate: randomized, double-blind study","volume":"33","author":"Thilothammal","year":"1996","journal-title":"Indian Pediatrics"},{"key":"10.1002\/14651858.CD001769.pub2-BIB11|cit11","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1136\/bmj.290.6471.815","article-title":"Which drug for the adult epileptic patient: phenytoin or valproate?","volume":"290","author":"Turnbull","year":"1985","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD001769.pub2-BIB12|cit12","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1469-8749.1993.tb11616.x","article-title":"Psychiatric aspects of epilepsy in childhood treated with carbamazepine, phenytoin or sodium valproate: a random trial","volume":"35","author":"Berg","year":"1993","journal-title":"Developmental Medicine and Child Neurology"},{"issue":"6","key":"10.1002\/14651858.CD001769.pub2-BIB13|cit13","first-page":"194","article-title":"A comparison between carbamazepine, phenytoin and sodium valproate as single drug treatment in epilepsy [abstract]","volume":"150","author":"Callaghan","year":"1981","journal-title":"Irish Journal of Medical Science"},{"key":"10.1002\/14651858.CD001769.pub2-BIB14|cit14","first-page":"7","article-title":"A comparative study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy: a preliminary communication","volume":"27","author":"Callaghan","year":"1983","journal-title":"British Journal of Clinical Practice"},{"issue":"4","key":"10.1002\/14651858.CD001769.pub2-BIB15|cit15","first-page":"154","article-title":"A comparative study of carbamazepine, sodium valproate and phenytoin as monotherapy in epilepsy: an updated report [abstract]","volume":"153","author":"Callaghan","year":"1984","journal-title":"Irish Journal of Medical Science"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001769.pub2-BIB16|cit16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/ageing\/22.suppl_2.P10-a","article-title":"The impact of sodium valproate and phenytoin on cognitive function in elderly patients: results of a single-blind comparative study.","volume":"22","author":"Craig","year":"1993","journal-title":"Age and ageing"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD001769.pub2-BIB17|cit17","first-page":"S95","article-title":"Comparative study of valproic acid (VPA), phenytoin (PHT), phenobarbital (PB) and carbamazepine (CBZ) in patients with newly diagnosed epilepsy with partial complex seizures [abstract]","volume":"244","author":"Czapinski","year":"1997","journal-title":"Journal of Neurology"},{"issue":"Suppl","key":"10.1002\/14651858.CD001769.pub2-BIB18|cit18","doi-asserted-by":"publisher","first-page":"S162","DOI":"10.1016\/S0022-510X(97)85646-8","article-title":"Randomized 36-month comparative study of valproic acid (VPA), phenytoin (PHT), phenobarbital (PB) and carbamazepine (CBZ) efficacy in patients with newly diagnosed epilepsy with partial complex seizures","volume":"150","author":"Czapinski","year":"1997","journal-title":"Journal of the Neurological Sciences"},{"issue":"4","key":"10.1002\/14651858.CD001769.pub2-BIB19|cit19","first-page":"154","article-title":"A re-appraisal by control and seizure type of serum levels in previously untreated patients taking part in a prospective study comparing sodium valproate, phenytoin and carbamazepine as mono-therapy in epilepsy [abstract]","volume":"153","author":"Goggin","year":"1984","journal-title":"Irish Journal of Medical Science"},{"issue":"6","key":"10.1002\/14651858.CD001769.pub2-BIB20|cit20","first-page":"150","article-title":"Serum levels of sodium valproate, phenytoin and carbamazepine and seizure control in epilepsy.","volume":"79","author":"Goggin","year":"1986","journal-title":"Irish Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD001769.pub2-BIB21|cit21","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1528-1157.2000.tb00144.x","article-title":"A multicenter randomized controlled trial on the clinical impact of therapeutic drug monitoring in patients with newly diagnosed epilepsy. The Italian TDM Study Group in Epilepsy","volume":"41","author":"Jannuzzi","year":"2000","journal-title":"Epilepsia"},{"issue":"6","key":"10.1002\/14651858.CD001769.pub2-BIB22|cit22","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.yebeh.2003.08.033","article-title":"Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy","volume":"4","author":"Kaminow","year":"2003","journal-title":"Epilepsy and Behaviour"},{"issue":"1","key":"10.1002\/14651858.CD001769.pub2-BIB23|cit23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1600-0404.1995.tb00461.x","article-title":"Cognitive function and anticonvulsant therapy: effect of monotherapy in epilepsy","volume":"92","author":"Sabers","year":"1995","journal-title":"Acta Neurologica Scandinavica"},{"issue":"4","key":"10.1002\/14651858.CD001769.pub2-BIB24|cit24","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.yebeh.2007.02.011","article-title":"How reliable is early treatment response in predicting long-term seizure outcome?","volume":"10","author":"Schmidt","year":"2007","journal-title":"Epilepsy and Behaviour"},{"key":"10.1002\/14651858.CD001769.pub2-BIB25|cit25","first-page":"7","article-title":"Sodium valproate, phenytoin and carbamazepine as sole anticonvulsants","volume":"30","author":"Shakir","year":"1980","journal-title":"Royal Society of Medicine International Congress and Symposium"},{"key":"10.1002\/14651858.CD001769.pub2-BIB26|cit26","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1093\/ageing\/23.suppl_2.P5-c","article-title":"Multicentre comparative trial of sodium valproate and phenytoin in elderly patients with newly diagnosed epilepsy","volume":"23","author":"Tallis","year":"1994","journal-title":"Age and ageing"},{"issue":"Suppl 7","key":"10.1002\/14651858.CD001769.pub2-BIB27|cit27","first-page":"62","article-title":"Multicenter comparative trial of valproate and phenytoin","volume":"35","author":"Tallis","year":"1994","journal-title":"Epilepsia"},{"issue":"1","key":"10.1002\/14651858.CD001769.pub2-BIB28|cit28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1136\/jnnp.45.1.55","article-title":"A comparison of phenytoin and valproate in previously untreated adult epileptic patients","volume":"45","author":"Turnbull","year":"1982","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD001769.pub2-BIB29|cit29","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1212\/WNL.33.11.1474","article-title":"Comparison of valproic acid and phenytoin in newly diagnosed tonic-clonic seizures","volume":"33","author":"Wilder","year":"1983","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD001769.pub2-BIB30|cit30","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.clineuro.2009.12.014","article-title":"Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients","volume":"112","author":"Zeng","year":"2010","journal-title":"Clinical Neurology and Neurosurgery"},{"issue":"2","key":"10.1002\/14651858.CD001769.pub2-BIB31|cit31","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1528-1157.1988.tb04407.x","article-title":"Interobserver variability in the ILAE classification of seizures in childhood","volume":"29","author":"Bodensteiner","year":"1988","journal-title":"Epilepsia"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001769.pub2-BIB32|cit32","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1111\/j.1528-1157.1987.tb05769.x","article-title":"Monotherapy with valproate in primary generalized epilepsies","volume":"28","author":"Bourgeois","year":"1987","journal-title":"Epilepsia"},{"issue":"3","key":"10.1002\/14651858.CD001769.pub2-BIB33|cit33","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S0011-393X(00)88522-7","article-title":"Pilot study of divalproex sodium valproate versus valproic acid: drug acquisition costs versus all related costs","volume":"60","author":"Brasfield","year":"1999","journal-title":"Current Therapeutic Research"},{"issue":"6","key":"10.1002\/14651858.CD001769.pub2-BIB34|cit34","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1136\/jnnp-2012-304270","article-title":"The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs","volume":"84","author":"Bromley","year":"2013","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD001769.pub2-BIB35|cit35","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1111\/j.1528-1157.1999.tb00851.x","article-title":"Malformations in offspring of women with epilepsy: A prospective study","volume":"40","author":"Canger","year":"1999","journal-title":"Epilepsia"},{"issue":"2","key":"10.1002\/14651858.CD001769.pub2-BIB36|cit36","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/j.1528-1157.1992.tb02330.x","article-title":"Phenytoin-folate interactions: differing effects of the sodium salt and the free acid of phenytoin","volume":"33","author":"Carl","year":"1992","journal-title":"Epilepsia"},{"issue":"5","key":"10.1002\/14651858.CD001769.pub2-BIB37|cit37","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1111\/j.1528-1157.1994.tb05980.x","article-title":"Valproate in the treatment of partial epilepsies","volume":"35","author":"Chadwick","year":"1994","journal-title":"Epilepsia"},{"issue":"8968","key":"10.1002\/14651858.CD001769.pub2-BIB38|cit38","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S0140-6736(95)91208-8","article-title":"Remission of epilepsy: results from the National General Practice Study of Epilepsy","volume":"346","author":"Cockerell","year":"1995","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD001769.pub2-BIB39|cit39","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1528-1157.1981.tb06159.x","article-title":"Proposal for revised clinical and electroencephalographic classification of epileptic seizures","volume":"22","year":"1981","journal-title":"Epilepsia"},{"issue":"4","key":"10.1002\/14651858.CD001769.pub2-BIB40|cit40","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","article-title":"Proposal for revised classification of epilepsies and epileptic syndromes","volume":"30","year":"1989","journal-title":"Epilepsia"},{"issue":"7","key":"10.1002\/14651858.CD001769.pub2-BIB41|cit41","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/j.1528-1157.1998.tb01167.x","article-title":"Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy","volume":"39","year":"1998","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001769.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1093\/ajhp\/54.15.1716","article-title":"Clinical and economic impact of replacing divalproex sodium with valproic acid","volume":"54","author":"Cranor","year":"1997","journal-title":"American Journal of Health-System Pharmacy"},{"issue":"3","key":"10.1002\/14651858.CD001769.pub2-BIB43|cit43","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1212\/WNL.34.3.285","article-title":"Juvenile myoclonic epilepsy of Janz","volume":"34","author":"Delgado-Escueta","year":"1984","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD001769.pub2-BIB44|cit44","first-page":"65","article-title":"Weight gain during treatment with valproate","volume":"69","author":"Dinesen","year":"1984","journal-title":"Acta Neurologica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD001769.pub2-BIB45|cit45","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S1059-1311(97)80065-9","article-title":"Weight gain with valproate or carbamazepine-a reappraisal.","volume":"6","author":"Easter","year":"1997","journal-title":"Seizure"},{"issue":"6291","key":"10.1002\/14651858.CD001769.pub2-BIB46|cit46","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1136\/bmj.283.6291.577","article-title":"Effects of sodium valproate in 100 children with special reference to weight","volume":"283","author":"Egger","year":"1981","journal-title":"British Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD001769.pub2-BIB47|cit47","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0890-6238(92)90181-R","article-title":"Course of pregnancy and fetal outcome following maternal exposure to carbamazepine and phenytoin: a prospective study","volume":"6","author":"Gladstone","year":"1992","journal-title":"Reproductive Toxicology"},{"key":"10.1002\/14651858.CD001769.pub2-BIB48|cit48","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001769.pub2-BIB49|cit49","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"7","key":"10.1002\/14651858.CD001769.pub2-BIB50|cit50","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/j.1528-1167.2006.00585.x","article-title":"ILAE treatment guidelines:Evidence based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes","volume":"47","author":"Glauser","year":"2006","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001769.pub2-BIB51|cit51","first-page":"542","article-title":"Choice of drug therapy in epilepsy","volume":"219","author":"Jeavons","year":"1977","journal-title":"Practitioner"},{"issue":"7048","key":"10.1002\/14651858.CD001769.pub2-BIB52|cit52","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1136\/bmj.313.7048.36","article-title":"Trials to assess equivalence: the importance of rigorous methods","volume":"313","author":"Jones","year":"1996","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD001769.pub2-BIB53|cit53","doi-asserted-by":"publisher","first-page":"c365","DOI":"10.1136\/bmj.c365","article-title":"The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews","volume":"340","author":"Kirkham","year":"2010","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001769.pub2-BIB54|cit54","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"5","key":"10.1002\/14651858.CD001769.pub2-BIB55|cit55","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1111\/j.1528-1157.1994.tb02549.x","article-title":"Absence seizures and carbamazepine in adults","volume":"35","author":"Liporace","year":"1994","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001769.pub2-BIB56|cit56","volume-title":"Idiopathic generalised epilepsies: clinical, experimental and genetic","author":"Malafosse","year":"1994"},{"issue":"3","key":"10.1002\/14651858.CD001769.pub2-BIB57|cit57","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001030","article-title":"Carbamazepine versus valproate monotherapy for epilepsy","author":"Marson","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9566","key":"10.1002\/14651858.CD001769.pub2-BIB58|cit58","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/S0140-6736(07)60460-7","article-title":"The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial","volume":"369","author":"Marson","year":"2007","journal-title":"The Lancet"},{"issue":"3","key":"10.1002\/14651858.CD001769.pub2-BIB59|cit59","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJM198507183130303","article-title":"Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures","volume":"313","author":"Mattson","year":"1985","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001769.pub2-BIB60|cit60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eplepsyres.2008.04.022","article-title":"Pregnancy outcomes in women with epilepsy: A systematic review and meta-analysis of published pregnancy registries and cohorts","volume":"81","author":"Meador","year":"2008","journal-title":"Epilepsy Research"},{"issue":"2","key":"10.1002\/14651858.CD001769.pub2-BIB61|cit61","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1136\/jnnp.2005.074203","article-title":"Pregnancy outcomes in women with epilepsy: A systematic review and meta-analysis of published pregnancy registries and cohorts","volume":"77","author":"Morrow","year":"2006","journal-title":"Journal of Neurology, Neurosurgery and Neuropsychiatry\u00a0"},{"issue":"8","key":"10.1002\/14651858.CD001769.pub2-BIB62|cit62","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1177\/088307389901400802","article-title":"Risk of excessive weight gain in epileptic children treated with valproate.","volume":"14","author":"Novak","year":"1999","journal-title":"Journal of Child Neurology"},{"issue":"1","key":"10.1002\/14651858.CD001769.pub2-BIB63|cit63","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/(SICI)1096-8628(19970110)68:1<18::AID-AJMG4>3.0.CO;2-U","article-title":"Findings in children exposed in utero to phenytoin and carbamazepine monotherapy: independent effects of epilepsy and medications","volume":"68","author":"Nulman","year":"1997","journal-title":"American Journal of Medical Genetics"},{"issue":"1","key":"10.1002\/14651858.CD001769.pub2-BIB64|cit64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.reprotox.2009.02.014","article-title":"Valproic acid in pregnancy: How much are we endangering the embryo and fetus?","volume":"28","author":"Ornoy","year":"2009","journal-title":"Reproductive Toxicology"},{"issue":"12","key":"10.1002\/14651858.CD001769.pub2-BIB65|cit65","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1212\/WNL.43.12.2526","article-title":"Reliability of seizure classification using a semistructured interview","volume":"43","author":"Ottman","year":"1993","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD001769.pub2-BIB66|cit66","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analysis of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD001769.pub2-BIB67|cit67","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1111\/j.1528-1157.1989.tb05833.x","article-title":"Juvenile myoclonic epilepsy: long term response to therapy","volume":"30","author":"Penry","year":"1989","journal-title":"Epilepsia"},{"issue":"3","key":"10.1002\/14651858.CD001769.pub2-BIB68|cit68","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5070\/D32197W4T4","article-title":"Phenytoin in cutaneous medicine: Its uses, mechanisms and side effects","volume":"9","author":"Scheinfeld","year":"2003","journal-title":"Dermatology Online Journal"},{"key":"10.1002\/14651858.CD001769.pub2-BIB69|cit69","unstructured":"StataCorp Stata Statistical Software: Release 11 2009"},{"issue":"7","key":"10.1002\/14651858.CD001769.pub2-BIB70|cit70","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1474-4422(11)70107-7","article-title":"Dose-dependent risk of malformation with antiepileptic drugs: An analysis of data from the EURAP epilepsy and pregnancy registry","volume":"10","author":"Tomson","year":"2011","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD001769.pub2-BIB71|cit71","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1528-1157.1975.tb04761.x","article-title":"Paradoxical intoxication - a complication of anticonvulsant administration","volume":"16","author":"Troupin","year":"1975","journal-title":"Epilepsia"},{"issue":"8","key":"10.1002\/14651858.CD001769.pub2-BIB72|cit72","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1745-6215-8-34","article-title":"Multiple treatment comparisons in epilepsy monotherapy trials.","volume":"5","author":"Tudur Smith","year":"2007","journal-title":"Trials"},{"key":"10.1002\/14651858.CD001769.pub2-BIB73|cit73","first-page":"27","article-title":"Progressive encephalopathy due to chronic hydantoin intoxication","volume":"128","author":"Vallarta","year":"1974","journal-title":"American Journal of Diseases of Children"},{"key":"10.1002\/14651858.CD001769.pub2-BIB74|cit74","unstructured":"Wallace H Shorvon SD Hopkins A O'Donoghue M National Society of Epilepsy Guidelines London: Royal College of Physicians 1997"},{"key":"10.1002\/14651858.CD001769.pub2-BIB75|cit75","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1212\/WNL.33.6.808","article-title":"Gastrointestinal tolerance of divalproex sodium","volume":"33","author":"Wilder","year":"1983","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD001769.pub2-BIB76|cit76","first-page":"339","article-title":"Phenytoin: clinical use","volume-title":"Antiepileptic drugs","author":"Wilder","year":"1995"},{"issue":"11","key":"10.1002\/14651858.CD001769.pub2-BIB77|cit77","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1002\/sim.1303","article-title":"Aggregate data meta-analysis with time-to-event outcomes","volume":"21","author":"Williamson","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"4","key":"10.1002\/14651858.CD001769.pub2-BIB78|cit78","article-title":"Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures","author":"Tudur Smith","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd001769.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,4,28]],"date-time":"2016-04-28T00:00:00Z","timestamp":1461801600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD001769.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T12:37:52Z","timestamp":1646397472000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD001769.pub2"}},"subtitle":[],"editor":[{"given":"Sarah J","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,8,23]]},"references-count":78,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001769.pub2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718082738.793484600","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2013,8,23]]}}}